Lehmen Jeff A, Gerber Edward J
Spine Midwest, Inc., 200 St. Mary's Plaza, Suite 301, Jefferson City, MO, 65101, USA,
Eur Spine J. 2015 Apr;24 Suppl 3:287-313. doi: 10.1007/s00586-015-3886-1. Epub 2015 Apr 8.
Over the past decade, the minimally disruptive lateral transpsoas approach for lumbar interbody fusion (MI-LIF) is increasingly being used as an alternative to conventional surgical approaches. The purpose of this review was to evaluate four primary questions as they relate to MI-LIF: (1) Is there an anatomical justification for MI-LIF at L4-5? (2) What are the complication and outcome profiles of MI-LIF and are they acceptable with respect to conventional approaches? (3) Given technical and neuromonitoring differences between various MI-LIF procedures, are there any published clinical differences? And, (4) are modern minimally disruptive procedures (e.g., MI-LIF) economically viable?
Through a MEDLINE and Google Scholar search, a total of 237 articles that discussed MI-LIF were identified. Of those, topical areas included anatomy (22), biomechanics/testing (17), technical descriptions (11), case reports (40), complications (30), clinical and radiographic outcomes (43), deformity (23), trauma or thoracic applications (10), and review articles (41).
In answer to the questions posed, (1) there is a high strength of evidence showing MI-LIF to be anatomically justified at all levels of the lumbar spine from L1-2 to L4-5. The evidence also supports the use of advanced neuromonitoring modalities. (2) There is moderate strength evidence in support of reproducible and reasonable complication, side effect, and outcome profiles following MI-LIF which may be technique dependent. (3) There is low-strength evidence that shows elevated neural complication rates in non-traditional (e.g., shallow-docking approaches and/or those without specialized neuromonitoring) MI-LIF, and (4) there is low- to moderate-strength evidence that modern minimally disruptive surgical approaches are cost-effective.
There is considerable published evidence to support MI-LIF in spinal fusion and advanced applications, though the results of some reports, especially concerning complications, vary greatly depending on technique and instrumentation used. Additional cost-effectiveness analyses would assist in fully understanding the long-term implications of MI-LIF.
在过去十年中,用于腰椎椎间融合术的微创经腰大肌外侧入路(MI-LIF)越来越多地被用作传统手术入路的替代方法。本综述的目的是评估与MI-LIF相关的四个主要问题:(1)L4-5节段行MI-LIF是否有解剖学依据?(2)MI-LIF的并发症和结果概况如何,与传统手术入路相比是否可接受?(3)鉴于各种MI-LIF手术在技术和神经监测方面存在差异,是否有已发表的临床差异?以及(4)现代微创技术(如MI-LIF)在经济上是否可行?
通过对MEDLINE和谷歌学术的检索,共识别出237篇讨论MI-LIF的文章。其中,主题领域包括解剖学(22篇)、生物力学/测试(17篇)、技术描述(11篇)、病例报告(40篇)、并发症(30篇)、临床和影像学结果(43篇)、畸形(23篇)、创伤或胸椎应用(10篇)以及综述文章(41篇)。
针对提出的问题,(1)有强有力的证据表明,从L1-2到L4-5的所有腰椎节段行MI-LIF在解剖学上是合理的。证据还支持使用先进的神经监测方式。(2)有中等强度的证据支持MI-LIF术后可重复且合理的并发症、副作用和结果概况,这可能取决于技术。(3)有低强度的证据表明,非传统的(如浅对接入路和/或没有专门神经监测的入路)MI-LIF神经并发症发生率升高,并且(4)有低到中等强度的证据表明现代微创外科手术方法具有成本效益。
有大量已发表的证据支持MI-LIF在脊柱融合及高级应用中的应用,尽管一些报告的结果,尤其是关于并发症的结果,因所使用的技术和器械不同而有很大差异。额外的成本效益分析将有助于全面了解MI-LIF的长期影响。